通过专为投资者打造的一站式数据看板，全面查看 Inhibrx Biosciences Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

1.50B

股息TTM

0.00

市盈率 TTM

-12.18

每股收益TTM

-8.39

营业收入

1.30M

净利润

1.69B

净资产收益率

-354.69%

总资产收益率

-61.03%

Inhibrx Biosciences Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-26.26%-2.34

23.37%-2.15

31.67%-2.11

19.68%-2.28

-101.46%-1.85

-94.07%-2.80

-78.82%-3.09

-158.18%-2.84

11888.42%127.10

-28.53%-1.44

-83.08%-1.73

---1.10

---1.08

---1.12

---0.94

----

营业收入

-100.00%0.00

----

-100.00%0.00

--0.00

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

-100.00%0.00

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

净利润

-27.91%-36.65M

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

利润率

----

-100.12%-2204.15%

----

-735.56%-47865.00%

----

1284.65%1858011.00%

----

61.64%-5728.52%

---43520.17%

---156840.00%

---287741.18%

---14932.48%

----

毛利率

----

0.00%100.00%

----

0.00%100.00%

----

0.00%100.00%

----

0.00%100.00%

--100.00%

----

资产负债率

144.22%114.31%

133.96%95.12%

--68.65%

--56.30%

--46.80%

-43.65%40.66%

-100.00%0.00%

-9.94%72.15%

-3.24%67.22%

--55.19%

--95.92%

--80.12%

--69.47%

----

利润表

营业收入

-100.00%0.00

----

-100.00%0.00

--0.00

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

-100.00%0.00

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

营业利润

-17.38%-32.15M

27.91%-30.93M

38.06%-30.92M

27.75%-33.81M

82.98%-27.39M

41.89%-42.90M

43.45%-49.93M

-2.12%-46.80M

-289.22%-160.90M

-68.68%-73.83M

-148.70%-88.29M

-52.74%-45.83M

-19.49%-41.34M

-50.83%-43.77M

-82.95%-35.50M

-59.58%-30.00M

-74.72%-34.60M

-56.36%-29.02M

-13.43%-19.40M

-20.84%-18.80M

净利润

-27.91%-36.65M

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

资产负债表

流动资产

-26.68%142.21M

-23.30%171.34M

-17.19%132.83M

-22.19%161.42M

-19.87%193.96M

-18.63%223.39M

-45.69%160.40M

-42.90%207.45M

19.05%242.06M

12.62%274.54M

5.30%295.36M

136.28%363.30M

11.95%203.32M

62.08%243.78M

101.63%280.49M

29.17%153.75M

38.35%181.62M

32.63%150.40M

5.25%139.11M

-9.72%119.03M

流动负债总额

-27.93%28.06M

-39.25%26.51M

-17.02%33.80M

-18.40%35.98M

-0.29%38.94M

-39.28%43.64M

-27.67%40.73M

23.27%44.09M

24.65%39.05M

120.19%71.87M

104.21%56.31M

40.69%35.77M

29.45%31.33M

62.35%32.64M

22.81%27.58M

1.10%25.43M

11.67%24.20M

-27.81%20.11M

-28.49%22.45M

-27.60%25.15M

总资产

-27.29%154.22M

-24.18%183.97M

-18.97%146.48M

-20.26%177.47M

-17.92%212.12M

-15.92%242.64M

-41.29%180.77M

-40.29%222.56M

21.23%258.42M

13.74%288.58M

5.85%307.89M

126.10%372.73M

10.33%213.17M

57.41%253.72M

93.34%290.88M

27.62%164.85M

36.17%193.21M

29.46%161.18M

4.67%150.45M

-10.01%129.18M

总负债

44.33%207.20M

38.33%205.00M

193.51%138.49M

218.95%140.64M

267.61%143.56M

-46.50%148.20M

-82.15%47.18M

-81.86%44.09M

-83.59%39.05M

16.11%277.01M

13.56%264.39M

21.63%243.14M

20.11%237.98M

78.27%238.58M

137.41%232.82M

97.97%199.90M

103.07%198.13M

109.41%133.83M

43.65%98.07M

94.84%100.98M

总权益

-177.27%-52.98M

-122.27%-21.04M

-94.02%7.99M

-79.36%36.83M

-68.75%68.56M

716.42%94.44M

207.07%133.58M

37.71%178.47M

984.11%219.37M

-23.56%11.57M

-25.07%43.50M

469.74%129.59M

-404.10%-24.81M

-44.67%15.13M

10.83%58.06M

-224.29%-35.05M

-111.11%-4.92M

-54.86%27.35M

-30.59%52.38M

-69.26%28.20M

现金流量表

经营净额

0.12%-29.92M

-5.94%-38.03M

31.10%-30.12M

-11.70%-33.82M

47.78%-29.95M

43.07%-35.90M

23.06%-43.72M

44.18%-30.28M

-35.60%-57.36M

-57.85%-63.05M

-85.69%-56.82M

-75.90%-54.24M

-57.12%-42.30M

-48.26%-39.94M

-35.28%-30.60M

-125.51%-30.84M

-20.29%-26.92M

-24.45%-26.94M

-46.99%-22.62M

1.49%-13.68M

投资净额

--0.00

100.00%0.00

97.17%-7.00K

100.00%0.00

98.12%-21.00K

99.54%-16.00K

69.54%-247.00K

-283.28%-1.22M

-4765.22%-1.12M

-1189.14%-3.44M

-4155.00%-811.00K

1.55%-317.00K

80.34%-23.00K

0.00%-267.00K

111.83%20.00K

10.31%-322.00K

-735.71%-117.00K

56.37%-267.00K

43.48%-169.00K

融资净额

--1.60M

-24.42%75.46M

--1.25M

--352.00K

-100.00%0.00

157.80%99.84M

-100.00%0.00

3758.31%32.95M

10778.65%38.73M

-99.46%860.00K

39404.15%199.89M

-98.58%854.00K

-99.09%356.00K

282.46%158.66M

-38.29%506.00K

48.63%60.16M

3870.04%39.22M

144.08%41.48M

-99.40%820.00K

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Inhibrx Biosciences Inc的总收入是多少？



根据Inhibrx Biosciences Inc的FY2025财报，总收入达到了1.30M（同比变化200.00K）。

Inhibrx Biosciences Inc的流动资产是多少？



根据Inhibrx Biosciences Inc的FY2025财报，流动资产为132.83M（同比变化-17.19）。

Inhibrx Biosciences Inc的总资产是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的总资产为146.48M（同比变化-18.97）。

Inhibrx Biosciences Inc的总负债是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的总负债为138.49M（同比变化193.51）。

Inhibrx Biosciences Inc的总权益是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的总权益为7.99M（同比变化-94.02）。

Inhibrx Biosciences Inc的净营业收入是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的净营业收入为-135.03M（同比变化59.26）。

Inhibrx Biosciences Inc的净投资是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的净投资为-28.00K（同比变化98.92）。

Inhibrx Biosciences Inc的净融资是多少？



根据Inhibrx Biosciences Inc的FY2025财报，Inhibrx Biosciences Inc的净融资为101.45M（同比变化41.53）。

Inhibrx Biosciences Inc的每股收益（EPS）是多少？



根据Inhibrx Biosciences Inc的FY2025财报，每股收益（EPS）为-9.04（同比变化-107.93）。

Inhibrx Biosciences Inc的净利润是多少？



根据Inhibrx Biosciences Inc的FY2025财报，净利润为-140.06M（同比变化-108.30）。

Inhibrx Biosciences Inc的净利润率是多少？



根据Inhibrx Biosciences Inc的FY2025财报，净利润率为-10773.46（同比变化-101.28）。

Inhibrx Biosciences Inc的股东权益回报率（ROE）是多少？



根据Inhibrx Biosciences Inc的FY2025财报，股东权益回报率（ROE）为-197.85（同比变化-110.38）。

Inhibrx Biosciences Inc的资产回报率（ROA）是多少？



根据Inhibrx Biosciences Inc的FY2025财报，资产回报率（ROA）为-85.60（同比变化-112.39）。

Inhibrx Biosciences Inc的营业利润是多少？



根据Inhibrx Biosciences Inc的FY2025财报，营业利润为-135.03M（同比变化59.26）。